Development of a bioartificial liver employing xenogeneic hepatocytes View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1997-01

AUTHORS

Wei-Shou Hu, Julie R. Friend, Florence J. Wu, Timothy Sielaff, Madhusudan V. Peshwa, Arye Lazar, Scott L. Nyberg, Rory P. Remmel, Frank B. Cerra

ABSTRACT

Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations. More... »

PAGES

29-38

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1007906512616

DOI

http://dx.doi.org/10.1023/a:1007906512616

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002483814

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22358518


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/10", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Technology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hu", 
        "givenName": "Wei-Shou", 
        "id": "sg:person.01064261433.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064261433.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Friend", 
        "givenName": "Julie R.", 
        "id": "sg:person.0642163715.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642163715.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wu", 
        "givenName": "Florence J.", 
        "id": "sg:person.01365570015.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365570015.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sielaff", 
        "givenName": "Timothy", 
        "id": "sg:person.0667256104.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667256104.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peshwa", 
        "givenName": "Madhusudan V.", 
        "id": "sg:person.01306202160.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306202160.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lazar", 
        "givenName": "Arye", 
        "id": "sg:person.016461535432.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016461535432.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
            "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nyberg", 
        "givenName": "Scott L.", 
        "id": "sg:person.01260246357.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260246357.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicinal Chemistry, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Department of Medicinal Chemistry, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Remmel", 
        "givenName": "Rory P.", 
        "id": "sg:person.01267470403.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267470403.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN", 
          "id": "http://www.grid.ac/institutes/grid.17635.36", 
          "name": [
            "Department of Surgery, University of Minnesota, 55455\u20130132, Minneapolis, MN"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cerra", 
        "givenName": "Frank B.", 
        "id": "sg:person.015711213420.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015711213420.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/978-3-642-96629-3_43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007304278", 
          "https://doi.org/10.1007/978-3-642-96629-3_43"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-96629-3_41", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000888130", 
          "https://doi.org/10.1007/978-3-642-96629-3_41"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02634282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020247813", 
          "https://doi.org/10.1007/bf02634282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02782889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082827506", 
          "https://doi.org/10.1007/bf02782889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02722946", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028865471", 
          "https://doi.org/10.1007/bf02722946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02626175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032988930", 
          "https://doi.org/10.1007/bf02626175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01307531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020837436", 
          "https://doi.org/10.1007/bf01307531"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-01", 
    "datePublishedReg": "1997-01-01", 
    "description": "Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1007906512616", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1086307", 
        "issn": [
          "1381-5741", 
          "1573-0603"
        ], 
        "name": "Cytotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1-3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "23"
      }
    ], 
    "keywords": [
      "hollow fiber bioreactor", 
      "liver-specific functions", 
      "higher liver-specific functions", 
      "anticipated clinical applications", 
      "mixture of spheroids", 
      "bioartificial liver", 
      "large-scale preparation", 
      "liver-specific metabolic activity", 
      "self-assembled spheroids", 
      "collagen entrapment", 
      "tank bioreactor", 
      "bioreactor system", 
      "canine liver failure model", 
      "hepatocyte spheroids", 
      "liver-specific activity", 
      "bioreactor", 
      "anhepatic rabbits", 
      "rate control", 
      "flow rate control", 
      "high yield", 
      "clinical applications", 
      "surface requirements", 
      "monolayers", 
      "xenogeneic hepatocytes", 
      "porcine hepatocytes", 
      "spheroid formation", 
      "protocol", 
      "spheroids", 
      "applications", 
      "conjugation", 
      "metabolic activity", 
      "liver failure model", 
      "preparation", 
      "oxygen measurements", 
      "entrapment", 
      "suspension", 
      "requirements", 
      "animal treatment", 
      "mixture", 
      "yield", 
      "possibility", 
      "sufficient number", 
      "viability", 
      "biosynthesis", 
      "biotransformation", 
      "development", 
      "system", 
      "proper degree", 
      "measurements", 
      "activity", 
      "formation", 
      "monolayer cultures", 
      "cells", 
      "high levels", 
      "end", 
      "hepatocytes", 
      "temporary support", 
      "order", 
      "control", 
      "first phase", 
      "phase", 
      "use", 
      "luminal side", 
      "function", 
      "side", 
      "investigation", 
      "support", 
      "culture", 
      "rat hepatocytes", 
      "test animals", 
      "number", 
      "perfusion protocol", 
      "collagen", 
      "scale", 
      "levels", 
      "degree", 
      "study", 
      "liver", 
      "further investigation", 
      "failure model", 
      "liver failure patients", 
      "rabbits", 
      "treatment", 
      "major cause", 
      "model", 
      "series", 
      "liver failure", 
      "tank", 
      "animals", 
      "failure", 
      "oxygenator", 
      "collagen gel contraction", 
      "gel contraction", 
      "dogs", 
      "warrants further investigation", 
      "contraction", 
      "rats", 
      "cause", 
      "survival", 
      "improved survival", 
      "failure patients", 
      "overdose", 
      "patients", 
      "mortality", 
      "fiber bioreactor", 
      "galactosamine overdose", 
      "large animal treatment", 
      "collagenase perfusion protocol", 
      "instrumented bioreactor system", 
      "improved clinical performance warrants further investigations", 
      "clinical performance warrants further investigations", 
      "performance warrants further investigations"
    ], 
    "name": "Development of a bioartificial liver employing xenogeneic hepatocytes", 
    "pagination": "29-38", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002483814"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1007906512616"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22358518"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1007906512616", 
      "https://app.dimensions.ai/details/publication/pub.1002483814"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:07", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_269.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1007906512616"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1007906512616'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      22 PREDICATES      147 URIs      131 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1007906512616 schema:about anzsrc-for:06
2 anzsrc-for:10
3 anzsrc-for:11
4 schema:author N58a0f0a8c9a04de8b860ca7a96bf5b49
5 schema:citation sg:pub.10.1007/978-3-642-96629-3_41
6 sg:pub.10.1007/978-3-642-96629-3_43
7 sg:pub.10.1007/bf01307531
8 sg:pub.10.1007/bf02626175
9 sg:pub.10.1007/bf02634282
10 sg:pub.10.1007/bf02722946
11 sg:pub.10.1007/bf02782889
12 schema:datePublished 1997-01
13 schema:datePublishedReg 1997-01-01
14 schema:description Liver failure is a major cause of mortality. A bioartificial liver (BAL) employing isolated hepatocytes can potentially provide temporary support for liver failure patients. We have developed a bioartificial liver by entrapping hepatocytes in collagen loaded in the luminal side of a hollow fiber bioreactor. In the first phase of development, liver-specific metabolic activities of biosynthesis, biotransformation and conjugation were demonstrated. Subsequently anhepatic rabbits were used to show that rat hepatocytes continued to function after the BAL was linked to the test animal. For scale-up studies, a canine liver failure model was developed using D-galactosamine overdose. In order to secure a sufficient number of hepatocytes for large animal treatment, a collagenase perfusion protocol was established for harvesting porcine hepatocytes at high yield and viability. An instrumented bioreactor system, which included dissolved oxygen measurement, pH control, flow rate control, an oxygenator and two hollow fiber bioreactors in series, was used for these studies. An improved survival of dogs treated with the BAL was shown over the controls. In anticipated clinical applications, it is desirable to have the liver-specific activities in the BAL as high as possible. To that end, the possibility of employing hepatocyte spheroids was explored. These self-assembled spheroids formed from monolayer culture exhibited higher liver-specific functions and remained viable longer than hepatocytes in a monolayer. To ease the surface requirement for large-scale preparation of hepatocyte spheroids, we succeeded in inducing spheroid formation in stirred tank bioreactors for both rat and porcine hepatocytes. These spheroids formed in stirred tanks were shown to be morphologically and functionally indistinguishable from those formed from a monolayer. Collagen entrapment of these spheroids resulted in sustaining their liver-specific functions at higher levels even longer than those of spheroids maintained in suspension. For use in the BAL, a mixture of spheroids and dispersed hepatocytes was used to ensure a proper degree of collagen gel contraction. This mixture of spheroids and dispersed cells entrapped in the BAL was shown to sustain the high level of liver-specific functions. The possibility of employing such a BAL for improved clinical performance warrants further investigations.
15 schema:genre article
16 schema:inLanguage en
17 schema:isAccessibleForFree true
18 schema:isPartOf N09c8da2bbc374ace948848ed422abc81
19 Na86496e47f0441d0b4c492bff70a09f4
20 sg:journal.1086307
21 schema:keywords activity
22 anhepatic rabbits
23 animal treatment
24 animals
25 anticipated clinical applications
26 applications
27 bioartificial liver
28 bioreactor
29 bioreactor system
30 biosynthesis
31 biotransformation
32 canine liver failure model
33 cause
34 cells
35 clinical applications
36 clinical performance warrants further investigations
37 collagen
38 collagen entrapment
39 collagen gel contraction
40 collagenase perfusion protocol
41 conjugation
42 contraction
43 control
44 culture
45 degree
46 development
47 dogs
48 end
49 entrapment
50 failure
51 failure model
52 failure patients
53 fiber bioreactor
54 first phase
55 flow rate control
56 formation
57 function
58 further investigation
59 galactosamine overdose
60 gel contraction
61 hepatocyte spheroids
62 hepatocytes
63 high levels
64 high yield
65 higher liver-specific functions
66 hollow fiber bioreactor
67 improved clinical performance warrants further investigations
68 improved survival
69 instrumented bioreactor system
70 investigation
71 large animal treatment
72 large-scale preparation
73 levels
74 liver
75 liver failure
76 liver failure model
77 liver failure patients
78 liver-specific activity
79 liver-specific functions
80 liver-specific metabolic activity
81 luminal side
82 major cause
83 measurements
84 metabolic activity
85 mixture
86 mixture of spheroids
87 model
88 monolayer cultures
89 monolayers
90 mortality
91 number
92 order
93 overdose
94 oxygen measurements
95 oxygenator
96 patients
97 performance warrants further investigations
98 perfusion protocol
99 phase
100 porcine hepatocytes
101 possibility
102 preparation
103 proper degree
104 protocol
105 rabbits
106 rat hepatocytes
107 rate control
108 rats
109 requirements
110 scale
111 self-assembled spheroids
112 series
113 side
114 spheroid formation
115 spheroids
116 study
117 sufficient number
118 support
119 surface requirements
120 survival
121 suspension
122 system
123 tank
124 tank bioreactor
125 temporary support
126 test animals
127 treatment
128 use
129 viability
130 warrants further investigation
131 xenogeneic hepatocytes
132 yield
133 schema:name Development of a bioartificial liver employing xenogeneic hepatocytes
134 schema:pagination 29-38
135 schema:productId N3814b38f5fd548ed979ed91c0d0a6cdb
136 Nca5997ac863b4c4897a42eb4cc710903
137 Nfd1333cc41114e7a9bc2512f1181fd41
138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002483814
139 https://doi.org/10.1023/a:1007906512616
140 schema:sdDatePublished 2022-01-01T18:07
141 schema:sdLicense https://scigraph.springernature.com/explorer/license/
142 schema:sdPublisher N10d00ca325c042b7b13c90455bc2a3a5
143 schema:url https://doi.org/10.1023/a:1007906512616
144 sgo:license sg:explorer/license/
145 sgo:sdDataset articles
146 rdf:type schema:ScholarlyArticle
147 N09a48ebb321b47c092d19b240fc491c4 rdf:first sg:person.016461535432.57
148 rdf:rest Nd25a24064ee348e58470c7d54745a28c
149 N09c8da2bbc374ace948848ed422abc81 schema:issueNumber 1-3
150 rdf:type schema:PublicationIssue
151 N10d00ca325c042b7b13c90455bc2a3a5 schema:name Springer Nature - SN SciGraph project
152 rdf:type schema:Organization
153 N3814b38f5fd548ed979ed91c0d0a6cdb schema:name pubmed_id
154 schema:value 22358518
155 rdf:type schema:PropertyValue
156 N56fd0138b72c4e97b7f282b9d4147a20 rdf:first sg:person.01365570015.47
157 rdf:rest N938956ccfe0047839b1c3fb53f9fa141
158 N58a0f0a8c9a04de8b860ca7a96bf5b49 rdf:first sg:person.01064261433.49
159 rdf:rest N8bb7f0825f4e405a8f688ab306f7efe1
160 N88ab3b8778e945fd91dc1f4bcd4ddf86 rdf:first sg:person.01267470403.44
161 rdf:rest Ne23e0348c9204ee1ab8fb1f0b9486d85
162 N8bb7f0825f4e405a8f688ab306f7efe1 rdf:first sg:person.0642163715.45
163 rdf:rest N56fd0138b72c4e97b7f282b9d4147a20
164 N938956ccfe0047839b1c3fb53f9fa141 rdf:first sg:person.0667256104.98
165 rdf:rest N9967e8ef8dcf43d083ec7a6d83fde197
166 N9967e8ef8dcf43d083ec7a6d83fde197 rdf:first sg:person.01306202160.55
167 rdf:rest N09a48ebb321b47c092d19b240fc491c4
168 Na86496e47f0441d0b4c492bff70a09f4 schema:volumeNumber 23
169 rdf:type schema:PublicationVolume
170 Nca5997ac863b4c4897a42eb4cc710903 schema:name dimensions_id
171 schema:value pub.1002483814
172 rdf:type schema:PropertyValue
173 Nd25a24064ee348e58470c7d54745a28c rdf:first sg:person.01260246357.46
174 rdf:rest N88ab3b8778e945fd91dc1f4bcd4ddf86
175 Ne23e0348c9204ee1ab8fb1f0b9486d85 rdf:first sg:person.015711213420.76
176 rdf:rest rdf:nil
177 Nfd1333cc41114e7a9bc2512f1181fd41 schema:name doi
178 schema:value 10.1023/a:1007906512616
179 rdf:type schema:PropertyValue
180 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
181 schema:name Biological Sciences
182 rdf:type schema:DefinedTerm
183 anzsrc-for:10 schema:inDefinedTermSet anzsrc-for:
184 schema:name Technology
185 rdf:type schema:DefinedTerm
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 sg:journal.1086307 schema:issn 1381-5741
190 1573-0603
191 schema:name Cytotechnology
192 schema:publisher Springer Nature
193 rdf:type schema:Periodical
194 sg:person.01064261433.49 schema:affiliation grid-institutes:grid.17635.36
195 schema:familyName Hu
196 schema:givenName Wei-Shou
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064261433.49
198 rdf:type schema:Person
199 sg:person.01260246357.46 schema:affiliation grid-institutes:grid.17635.36
200 schema:familyName Nyberg
201 schema:givenName Scott L.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260246357.46
203 rdf:type schema:Person
204 sg:person.01267470403.44 schema:affiliation grid-institutes:grid.17635.36
205 schema:familyName Remmel
206 schema:givenName Rory P.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01267470403.44
208 rdf:type schema:Person
209 sg:person.01306202160.55 schema:affiliation grid-institutes:grid.17635.36
210 schema:familyName Peshwa
211 schema:givenName Madhusudan V.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306202160.55
213 rdf:type schema:Person
214 sg:person.01365570015.47 schema:affiliation grid-institutes:grid.17635.36
215 schema:familyName Wu
216 schema:givenName Florence J.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365570015.47
218 rdf:type schema:Person
219 sg:person.015711213420.76 schema:affiliation grid-institutes:grid.17635.36
220 schema:familyName Cerra
221 schema:givenName Frank B.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015711213420.76
223 rdf:type schema:Person
224 sg:person.016461535432.57 schema:affiliation grid-institutes:grid.17635.36
225 schema:familyName Lazar
226 schema:givenName Arye
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016461535432.57
228 rdf:type schema:Person
229 sg:person.0642163715.45 schema:affiliation grid-institutes:grid.17635.36
230 schema:familyName Friend
231 schema:givenName Julie R.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642163715.45
233 rdf:type schema:Person
234 sg:person.0667256104.98 schema:affiliation grid-institutes:grid.17635.36
235 schema:familyName Sielaff
236 schema:givenName Timothy
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667256104.98
238 rdf:type schema:Person
239 sg:pub.10.1007/978-3-642-96629-3_41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000888130
240 https://doi.org/10.1007/978-3-642-96629-3_41
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/978-3-642-96629-3_43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007304278
243 https://doi.org/10.1007/978-3-642-96629-3_43
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/bf01307531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020837436
246 https://doi.org/10.1007/bf01307531
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/bf02626175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032988930
249 https://doi.org/10.1007/bf02626175
250 rdf:type schema:CreativeWork
251 sg:pub.10.1007/bf02634282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020247813
252 https://doi.org/10.1007/bf02634282
253 rdf:type schema:CreativeWork
254 sg:pub.10.1007/bf02722946 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028865471
255 https://doi.org/10.1007/bf02722946
256 rdf:type schema:CreativeWork
257 sg:pub.10.1007/bf02782889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082827506
258 https://doi.org/10.1007/bf02782889
259 rdf:type schema:CreativeWork
260 grid-institutes:grid.17635.36 schema:alternateName Department of Medicinal Chemistry, University of Minnesota, 55455–0132, Minneapolis, MN
261 Department of Surgery, University of Minnesota, 55455–0132, Minneapolis, MN
262 Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455–0132, Minneapolis, MN
263 schema:name Department of Medicinal Chemistry, University of Minnesota, 55455–0132, Minneapolis, MN
264 Department of Surgery, University of Minnesota, 55455–0132, Minneapolis, MN
265 Departments of Chemical Engineering and Materials Science, University of Minnesota, 55455–0132, Minneapolis, MN
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...